Acumino provides an AI‑driven analytics platform that automatically ingests, processes, and visualizes structured and unstructured data from multiple sources in real time. Using NLP and machine‑learning models, it categorizes, summarizes, and highlights key trends, delivering interactive dashboards and alerting tools that can be embedded into existing workflows via APIs and webhooks.

Contactile develops bio-inspired tactile sensor arrays that provide robots with a human-like sense of touch, enabling them to apply optimal grip force for various objects without additional programming. This technology addresses the limitation of traditional robotic grippers, which lack the tactile feedback necessary for intelligent and dexterous manipulation in real-world applications.

Cortical Labs develops biological computing systems that integrate lab-grown human neurons with silicon chips to create hybrid computing platforms. This technology enables more efficient data processing and complex problem-solving capabilities, addressing limitations in traditional computing architectures.

Diag-Nose.io develops the RhinoMAP platform to decode airway biology for respiratory diseases. This platform integrates nasal microsampling, proteomics, and machine learning algorithms to analyze biomarker data. The goal is to enable precision medicine by identifying root causes, leading to faster, more effective treatment selection for patients.

This startup produces animal-free dairy milk using precision fermentation to replicate the proteins and nutrients found in traditional cow's milk. Their products are vegan-friendly and lactose-free, providing a sustainable alternative that reduces the environmental impact of dairy farming.

Fable Food produces meat alternatives using shiitake mushrooms, providing a high-protein, umami-rich product that mimics the texture and flavor of meat. This approach addresses the demand for nutritious, plant-based options while minimizing environmental impact through sustainable sourcing and production practices.

FUL Foods produces a natural blue color extract, FUL® BLU, derived from spirulina phycocyanin for the food, beverage, and cosmetic industries. This patented extract offers superior heat and pH stability, making it a versatile, tasteless alternative to synthetic colorants. Beyond coloring, the ingredient provides functional benefits linked to antioxidant properties while utilizing a sustainable production process that captures CO2.

Marama Labs has developed patented Scatter-Free Absorption (SFA) technology that enhances UV-Vis spectroscopy by eliminating interference from scattered light, enabling accurate quantification of RNA and other biological molecules in nanoparticle formulations. This technology addresses the challenge of light scattering in samples such as liposomes and lipid nanoparticles, facilitating rapid and reliable analysis without prior knowledge of particle size or composition.

OncoRes Medical is developing an intraoperative imaging technology that combines optical coherence tomography (OCT) and elastography to provide real-time assessment of tissue microstructure during surgery. This technology enables surgeons to evaluate tissue characteristics with a resolution comparable to histology, improving decision-making and patient outcomes.

OpenStar Technologies is developing levitated dipole reactors using High Temperature Superconductors to generate baseload fusion power for the electrical grid. This technology aims to eliminate reliance on fossil fuels by providing a reliable and sustainable energy source.

Turnto utilizes AI to aggregate and simplify the latest health research, community insights, and expert advice into daily updates delivered through a mobile application. This approach addresses the lengthy and overwhelming process individuals face when seeking relevant information about their health conditions, enabling users to discover new treatment options in just five minutes.

Wilder World is a multiplayer metaverse platform that utilizes blockchain technology and artificial intelligence to create a decentralized economy where users can own and govern their digital assets. It addresses the lack of immersive virtual experiences by offering a vast, photorealistic environment for exploration, racing, and combat, enabling players to engage in a dynamic and interactive community.

Xylo develops next-generation therapeutics focused on rewiring neural circuits to restore brain function. The company combines advanced neuroscience with computational drug discovery to create optimized treatments for neurological and psychiatric conditions. Their pipeline aims to enhance neuroplasticity to address critical gaps in current disorder treatments.